Skip to content
★ Sign in to follow
Corentec Co., Ltd. logo

Corentec Co., Ltd. Stock: price and insider trades · South Korea

코렌텍

KR·Mcap ₩79.4BHealth Care

No insider purchase over the last 90 days. The latest, by 박형철, was filed 11 Jun 2026.

Corentec Co., Ltd.: what insiders have been doing

Corentec Co., Ltd. is a Health Care company. Its directors and officers file their transactions with DART (FSS). From 9 November 2025 to 9 November 2026, the disclosure feed for Corentec Co., Ltd. logged 8 filings by 3 insiders.

The record shows 7 purchases on the open market, made by 3 insiders, against 1 sale by 1 insider. The totals exclude 8 filings filed without an amount. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The buyers include 1 major shareholder, 1 board member and 1 senior executive.

The latest purchase dates back some time: it was published 151 days ago, on 11 June 2026. Between a trade and the moment it shows up on DART (FSS), the median delay is 7 days. This delay matters because a trade only becomes useful information once it is public.

For context, the typical company on the same exchange (median of 2,630 companies) published 7 filings over the same period, against 8 filings here. Our records for Corentec Co., Ltd. go back to 2021, with 17 purchases and 4 sales on the open market in total.

For comparison within the same sector, see the insider buying recorded at MAIA Biotechnology, Inc. and Cooper Companies, Inc. Source: insider filings from DART (FSS). Past trades are no guide to future returns.

Insider Decl.
144
Thresholds
n/a
Buy Volume
n/a
17 ops. · all time
Sell Volume
n/a
4 ops. · all time

Who traded when

BuySale
선두훈3 buys2 sales
박형철4 buys
한투한화디지털헬스케어제1호사모투자1 buy1 sale
선경훈1 buy
선승훈1 buy
Fundamental score
Ranked 3,644 of 26,913 companies
71.3
score / 100
Value
83
Quality
59
FCF yld31%
Earn yld8.4%
EV/EBITDA7.1x
ROE8.5%
Gross mgn52%
Net mgn6.2%
Debt/EBITDA2.0x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩5,920
Analyst consensus
·
Income statement
Revenue₩100.4B
Gross profit₩52.1B52% margin
EBITDA₩14.5B14% margin
Net income₩6.3B6.4% margin
Valuation
Beta0.27
Balance sheet & cash
Market cap₩79.4B
Total debt₩29.5B
Free Cash Flow₩22.9B
Debt / Equity31%
Profitability & ownership
ROE8.5%
ROA3.4%
% insiders18.7%
% institutions0.0%
Last declaration on 11 June 2026
Declarations144 total
  • ▲
    Executives
    0DART
    2,050 sharesShareKRXDART:20260611000209
    Canonical exit: 9 Sept 2026 (T+90)
  • ▲
    Executives
    0DART
    1,000 sharesShareKRXDART:20260605000289
    Canonical exit: 25 Aug 2026 (T+90)
  • ▲
    Executives
    0DART
    5,550 sharesShareKRXDART:20260605000139
    Canonical exit: 31 Aug 2026 (T+90)
  • ▲
    대량보유자Executives
    0DART
    11,254 sharesKRXDART:20260604000642
    Canonical exit: 26 Aug 2026 (T+90)
  • ▼
    대량보유자Executives
    0DART
    10,268 sharesKRXDART:20260604000380
  • ▲
    Executives
    0DART
    11,254 sharesShareKRXDART:20260604000454
    Canonical exit: 26 Aug 2026 (T+90)
  • ▲
    부사장Executives(filed)
    0DART
    2,000 sharesShareKRXDART:20260528000040
    Canonical exit: 26 Aug 2026 (T+90)
  • ▼
    Executives
    0DART
    10,268 sharesKRXDART:20260527000091
  • 778,204 sharesKRXDART:20260106000350
    Canonical exit: 29 Mar 2026 (T+90)
  • ▼
    대량보유자Executives
    0DART
    629,077 sharesKRXDART:20250902000107
  • ●
    Executives
    Executives
    0DART
  • ▲
    사내이사Executives
    0DART
    ShareKRXDART:20241205000133
    Canonical exit: 4 Mar 2025 (T+90)
  • ▲
    Executives
    0DART
    61,032 sharesKRXDART:20241205000139
    Canonical exit: 4 Mar 2025 (T+90)
  • ▲
    사내이사Executives
    0DART
    ShareKRXDART:20241205000136
    Canonical exit: 4 Mar 2025 (T+90)
  • ▲
    Executives
    0DART
    114,830 sharesKRXDART:20240904000438
    Canonical exit: 3 Dec 2024 (T+90)
  • ▲
    사내이사Executives
    0DART
    ShareKRXDART:20240904000431
    Canonical exit: 3 Dec 2024 (T+90)
  • ▲
    사내이사Executives
    0DART
    ShareKRXDART:20240904000433
    Canonical exit: 3 Dec 2024 (T+90)
  • ▲
    이사Executives
    0DART
    ShareKRXDART:20240806000010
    Canonical exit: 29 Oct 2024 (T+90)
  • ▲
    Executives
    0DART
    40,830 sharesKRXDART:20240605000130
    Canonical exit: 2 Sept 2024 (T+90)
  • ▲
    사내이사Executives
    0DART
    ShareKRXDART:20240605000129
    Canonical exit: 2 Sept 2024 (T+90)
  • ▲
    사내이사Executives
    0DART
    ShareKRXDART:20240605000127
    Canonical exit: 2 Sept 2024 (T+90)
  • ●
    Executives
    0DART
    0KRXDART:20240524000396
  • ●
    Executives
    0DART
    0KRXDART:20231011000109
  • ●
    Executives
    0DART
    0KRXDART:20230919000082
  • ●
    Executives
    0DART
    0KRXDART:20230721000123

25 of 144 declarations

About Corentec Co., Ltd.

Koreantec is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It specializes in the development and distribution of medical devices.